Do not take
AUBAGIO if you have severe liver problems, are pregnant or are of childbearing
potential and not using effective birth control, or are taking a
medication called leflunomide. View IMPORTANT SAFETY INFORMATION
Just taking some
time to listen and ask questions can be a great way to learn something
new. So we host a variety of informative events where you can get
answers about relapsing forms of multiple sclerosis (MS) and AUBAGIO® (teriflunomide). You’ll hear from experts and people
living with MS, plus hear about a once-a-day pill for MS. As part of your
participation at a live event, a meal may be provided.
Events coming
up in your area.
Have a
question about MS or an event?
Talk to an MS
One to One® Nurse 24/7 at 1-855-676-6326.
Please scroll
down for Important Safety Information.
AUBAGIO® (teriflunomide) is a prescription medicine used to treat
relapsing forms of multiple sclerosis (MS).
IMPORTANT SAFETY
INFORMATION
DO NOT TAKE
AUBAGIO IF YOU:
•
Have severe liver problems. AUBAGIO may cause serious
liver problems, which can be life-threatening. Your risk may be higher if you take
other medicines that affect your liver. Your healthcare provider should
do blood tests to check your liver within 6 months before you start
AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your
healthcare provider right away if you develop any of these symptoms of
liver problems: nausea, vomiting, stomach pain, loss of appetite,
tiredness, yellowing of your skin or whites of your eyes, or dark urine.
•
Take a medicine
called leflunomide for rheumatoid arthritis.
•
Are pregnant.
AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO.
After stopping AUBAGIO, continue to use effective birth control until you
have made sure your blood levels of AUBAGIO are lowered. If you become
pregnant while taking AUBAGIO or within 2 years after stopping, tell your
healthcare provider right away and enroll in the AUBAGIO Pregnancy
Registry at 1‑800‑745‑4447, option 2.
•
Are of
childbearing potential and not using effective birth control.
It is not known
if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you
should take AUBAGIO or breastfeed — you should not do both at the same
time.
If you are a man
whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your
healthcare provider about reducing the levels of AUBAGIO in your blood.
If your partner does not plan to become pregnant, use effective birth
control while taking AUBAGIO.
AUBAGIO may stay
in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that
can remove AUBAGIO from your blood quickly.
Before taking
AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you
are unable to fight infections; numbness or tingling in your hands or
feet that is different from your MS symptoms; diabetes; serious skin
problems when taking other medicines; breathing problems; or high blood
pressure. Your healthcare provider will check your blood cell count and
TB test before you start AUBAGIO. Talk with your healthcare provider if
you take or are planning to take other medicines (especially medicines
for treating cancer or controlling your immune system), vaccines,
vitamins or herbal supplements.
AUBAGIO may
cause serious side effects, including: reduced white blood cell count — this may cause you to
have more infections; numbness or tingling in your hands or feet that is
different from your MS symptoms; serious skin problems; breathing
problems (new or worsening); and high blood pressure.
The most common
side effects when taking AUBAGIO include: headache; diarrhea; nausea;
hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your
healthcare provider about any side effect that bothers you.
Consult your
healthcare provider if you have questions about your health or any
medications you may be taking, including AUBAGIO.
Please DO NOT
REPLY TO THIS EMAIL. Genzyme will not receive this message if you reply.
If you have any questions regarding this email or Genzyme, click here.
To unsubscribe
from our mailing list, please click here.
